Showing results (351-360 of 637) with videos related to
Sort By:
Pageof 64
CNS Drugs|July 18, 2016
The Effect of Safety Warnings on Antipsychotic Drug Prescribing in Elderly Persons with Dementia in the United Kingdom and Italy: A Population-Based StudyJanet Sultana, Andrea Fontana, Francesco Giorgianni, et al.Plos Medicine|February 7, 2018
Impact of person-centred care training and person-centred activities on quality of life, agitation, and antipsychotic use in people with dementia living in nursing homes: A cluster-randomised controlled trialClive Ballard, Anne Corbett, Martin Orrell, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 26, 2016
Synaptic proteins predict cognitive decline in Alzheimer's disease and Lewy body dementiaErika Bereczki, Paul T Francis, David Howlett, et al.International Journal of Geriatric Psychiatry|January 27, 2023
Impact of the Covid-19 pandemic on neuropsychiatric symptoms and antipsychotic prescribing for people with dementia in nursing home settingsJoanne McDermid, Clive Ballard, Zunera Khan, et al.Bjpsych Open|December 19, 2024
The SLaM Brain Health Clinic: remote biomarker enhanced memory clinic for people with mild cognitive impairment within a National Health Service mental health trustAshwin V Venkataraman, Pooja Kandangwa, Roos Lemmen, et al.International Journal of Geriatric Psychiatry|January 29, 2002
Can psychiatric liaison reduce neuroleptic use and reduce health service utilization for dementia patients residing in care facilitiesClive Ballard, Ian Powell, Ian James, et al.The American Journal of Psychiatry|November 21, 2015
Impact of Antipsychotic Review and Nonpharmacological Intervention on Antipsychotic Use, Neuropsychiatric Symptoms, and Mortality in People With Dementia Living in Nursing Homes: A Factorial Cluster-Randomized Controlled Trial by the Well-Being and Health for People With Dementia (WHELD) ProgramClive Ballard, Martin Orrell, Sun YongZhong, et al.Lancet (London, England)|January 13, 2012
Memantine for dementia in adults older than 40 years with Down's syndrome (MEADOWS): a randomised, double-blind, placebo-controlled trialMarisa Hanney, Vee Prasher, Nicola Williams, et al.Diagnostics (Basel, Switzerland)|May 4, 2026
Lifetime Exposure to Endogenous Estradiol and Markers of Dementia Risk: Associations with Later Life Cognitive, Behavioral, and Functional ComplaintsJasper F E Crockford, Dylan X Guan, Maryam Ghahremani, et al.Journal of Neuroinflammation|May 9, 2023
Inflammatory panel cytokines are elevated in the neocortex of late-stage Alzheimer's disease but not Lewy body dementiasYuek Ling Chai, Jasinda H Lee, Joyce R Chong, et al.Pageof 64